Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 480 shares of common stock on 02/20/2024, with an aggregate market value of $201,979.20. The shares to be sold were recently acquired on 02/17/2024, as part of compensation in the form of 240 performance shares and 240 shares from restricted stock vesting, both issued by the company. This transaction follows a previous sale of 314 shares by Tatsis in the past three months, which grossed $131,955.36. The notice for the upcoming sale was filed on the same day as the planned sale, with the instruction for this transaction having been adopted on 05/09/2023.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 480 shares of common stock on 02/20/2024, with an aggregate market value of $201,979.20. The shares to be sold were recently acquired on 02/17/2024, as part of compensation in the form of 240 performance shares and 240 shares from restricted stock vesting, both issued by the company. This transaction follows a previous sale of 314 shares by Tatsis in the past three months, which grossed $131,955.36. The notice for the upcoming sale was filed on the same day as the planned sale, with the instruction for this transaction having been adopted on 05/09/2023.
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年2月20日出售480股普通股，总市值为201,979.20美元。拟出售的股票最近于2024年2月17日被收购，作为补偿的一部分，公司发行了240股绩效股票和240股限制性股票归属股票。该交易是在塔西斯在过去三个月中出售314股股票之后进行的，总收入为131,955.36美元。即将进行的出售通知是在计划出售的同一天提交的，该交易的指示已于2023年9月5日通过。
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年2月20日出售480股普通股，总市值为201,979.20美元。拟出售的股票最近于2024年2月17日被收购，作为补偿的一部分，公司发行了240股绩效股票和240股限制性股票归属股票。该交易是在塔西斯在过去三个月中出售314股股票之后进行的，总收入为131,955.36美元。即将进行的出售通知是在计划出售的同一天提交的，该交易的指示已于2023年9月5日通过。
有用
没用